Information de reference pour ce titreAccession Number: | 00002591-199711220-00020.
|
Author: | MacDonald, T M; Morant, S V; Robinson, G C; Shield, M J; McGilchrist, M M; Murray, F E; McDevitt, D G
|
Institution: | Medicines Monitoring Unit, Department of Clinical Pharmacology, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY. T M MacDonald, reader in clinical pharmacology. M M McGilchrist, senior computer programmer. F E Murray, consultant gastroenterologist. D G McDevitt, professor of clinical pharmacology. Searle, PO Box 53, High Wycombe, Buckingharnshire HP12 4HL. S V Morant, statistician. G C Robinson, clinical project manager. M J Shield, medical director. Correspondence to: Dr MacDonald. BMJ 1997;315:1333-7.
|
Title: | Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study.[Article]
|
Source: | BMJ. 315(7119):1333-1337, November 22, 1997.
|
Abstract: | Objectives: To determine the profile of risk of upper gastrointestinal toxicity during continuous treatment with, and after cessation of, non-steroidal anti-inflammatory drugs.
Design: Cohort study with a prospectively constructed, population based, record linkage database containing details of exposure to all community dispensed non-steroidal anti-inflammatory drugs and also all admissions to hospital for upper gastrointestinal diagnoses.
Setting: The population of Tayside, Scotland.
Subjects: 52 293 subjects aged 50 and over who received one or more non-steroidal anti-inflammatory between 1 January 1989 and 31 December 1991 and 73 792 subjects who did not receive one during the same period (controls).
Main outcome measures: Admission to hospital for upper gastrointestinal bleeding and perforation, and admission for other upper gastrointestinal diagnoses.
Results: About 2% of the non-steroidal anti-inflammatory cohort were admitted with an upper gastrointestinal event during the study period compared with 1.4% of controls. The risk of admission for upper gastrointestinal haemorrhage and perforation was constant during continuous non-steroidal anti-inflammatory exposure and carried over after the end of exposure. The results were similar for admissions for all upper gastrointestinal events.
Conclusion: This study provides evidence that non-steroidal anti-inflammatory toxicity persists with continuous exposure. There seems to be carryover toxicity after the end of prescribing. These findings have implications for the management of patients requiring non-steroidal anti-inflammatory drugs.
(C) British Medical Journal 1997.
|
References: | 1. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;i:462-4.
2. Beard K, Walker AM, Perera DR, Jick H. Non-steroidal anti-inflammatory drugs and hospitalisation for gastroesophageal bleeding in the elderly. Arch Intern Med 1987;147:1621-3.
3. Carson JI., Strom BL, Morse ML, West SL, Soper KA, Stolley PD, et al. The association of non-steroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987;147:1054-9.
4. Henry DA, Johnston A, Dobson A, Duggan J. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. BMJ 1987;295:1227-9.
5. Griffin MR, Ray WA, Schaffner W. Non-steroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988;109:359-63.
6. Levy M, Miller DR, Kaufman DW, Siskind V, Schwingl P, Rosenberg L, et al. Major upper gastrointestinal tract bleeding. Arch Intern Med 1988;148:281-5.
7. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Block DA. Toward an epidemiology of gastropathy associated with non-steroidal anti-inflammatory drug use. Gastroenterology 1989;96:647-55.
8. Beardon PHG, Brown SV, McDevitt DG. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. QJ Med 1989;71:497-505.
9. Griffin MR, Piper JM, Daughtery J, Snowden M, Ray WA. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
10. Laporte J-R, Carne X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991;337:85-9.
11. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from non-aspirin, non-steroidal anti-inflammatory drugs. Gastroenterology 1993;105:1078-8.
12. Garcia-Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-72.
13. Langman MJS, Well J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
14. Carson JL, Strom BL, Morse ML, West SL, Soper KA, Stolley PD, et al. The relative gastrointestinal toxicity of the non-steroidal anti-inflammatory drugs. Arch Intern Med 1987;147:1054-9.
15. Graham DY, Smith JL, Spjut HJ, Torres F., Gastric adaptation: studies in humans during continuous aspirin administration. Gastroenterology 1988;95:327-33.
16. Shorrock CJ, Prescott RJ, Rees WDW. The effects of indomethacin on gastroduodenal morphology and mucosal pH gradient in the healthy human stomach. Gastroenterology 1990;99:334-9.
17. Moride Y, Abenheim L. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol 1994;47:731-7.
18. MacDonald TM, McDevitt DG. The Tayside medicines monitoring unit (MEMO) In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. Chichester: Wiley, 1994:245-55.
19. International Classification of Diseases. Manual of the international statistical classification of diseases, injuries and causes of death. Geneva: World Health Organisation, 1977.
20. Office of Population Census and Surveys. Tabular list of the classification of surgical operations and procedures. 4th rev. London: HMSO, 1990.
21. Dornan S, Murray FE, White G, McGilchrist MM, Evans JMM, MacDonald TM. Assessment of accuracy of upper gastrointestinal diagnoses in Scottish Morbidity Record 1 data in Tayside. Health Bull (Edinb) 1995;53:274-9.
22. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. London: Pharmaceutical Press, 1994:34-9. (No 28, September 1994.)
23. McCullagh P, Nelder JA. Monographs on statistics and applied probability 37: general linear models. 2nd ed. London: Chapman and Hall, 1989:193-244.
24. Beardon PHG, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ 1993;307:846-8.
|
Language: | English.
|
Document Type: | Papers.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0959-8138
|
NLM Journal Code: | 8900488, bmj, 101090866
|
Annotation(s) | |
|
|